140 related articles for article (PubMed ID: 19787263)
21. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
Izeradjene K; Douglas L; Delaney A; Houghton JA
Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of experimental HCC growth in mice by use of the kinase inhibitor DMAT.
Sass G; Klinger N; Sirma H; Hashemolhosseini S; Hellerbrand C; Neureiter D; Wege H; Ocker M; Tiegs G
Int J Oncol; 2011 Aug; 39(2):433-42. PubMed ID: 21567083
[TBL] [Abstract][Full Text] [Related]
23. Casein kinase 2 (CK2) increases survivin expression via enhanced beta-catenin-T cell factor/lymphoid enhancer binding factor-dependent transcription.
Tapia JC; Torres VA; Rodriguez DA; Leyton L; Quest AF
Proc Natl Acad Sci U S A; 2006 Oct; 103(41):15079-84. PubMed ID: 17005722
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and Anticancer Activity of Novel Dual Inhibitors of Human Protein Kinases CK2 and PIM-1.
Wińska P; Wielechowska M; Koronkiewicz M; Borowiecki P
Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514177
[TBL] [Abstract][Full Text] [Related]
25. Casein kinase-II inhibition promotes retinal ganglion cell survival and axonal regeneration.
Cen LP; Liu YF; Ng TK; Luo JM; van Rooijen N; Zhang M; Pang CP; Cui Q
Exp Eye Res; 2018 Dec; 177():153-159. PubMed ID: 30118655
[TBL] [Abstract][Full Text] [Related]
26. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
Ravi R; Bedi A
Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014
[TBL] [Abstract][Full Text] [Related]
27. p53 is dispensable for the induction of apoptosis after inhibition of protein kinase CK2.
Schneider CC; Hessenauer A; Montenarh M; Götz C
Prostate; 2010 Feb; 70(2):126-34. PubMed ID: 19760628
[TBL] [Abstract][Full Text] [Related]
28. Treatment of cultured human astrocytes and vascular endothelial cells with protein kinase CK2 inhibitors induces early changes in cell shape and cytoskeleton.
Kramerov AA; Golub AG; Bdzhola VG; Yarmoluk SM; Ahmed K; Bretner M; Ljubimov AV
Mol Cell Biochem; 2011 Mar; 349(1-2):125-37. PubMed ID: 21125314
[TBL] [Abstract][Full Text] [Related]
29. Biological properties and structural study of new aminoalkyl derivatives of benzimidazole and benzotriazole, dual inhibitors of CK2 and PIM1 kinases.
Chojnacki K; Wińska P; Wielechowska M; Łukowska-Chojnacka E; Tölzer C; Niefind K; Bretner M
Bioorg Chem; 2018 Oct; 80():266-275. PubMed ID: 29966873
[TBL] [Abstract][Full Text] [Related]
30. Novel Anthraquinone Derivatives as Dual Inhibitors of Topoisomerase 2 and Casein Kinase 2: In Silico Studies, Synthesis and Biological Evaluation on Leukemic Cell Lines.
Kabir A; Tilekar K; Upadhyay N; Ramaa CS
Anticancer Agents Med Chem; 2018; 18(11):1551-1562. PubMed ID: 29683096
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of CK2 enhances UV-triggered apoptotic cell death in lung cancer cell lines.
Zhao T; Jia H; Li L; Zhang G; Zhao M; Cheng Q; Zheng J; Li D
Oncol Rep; 2013 Jul; 30(1):377-84. PubMed ID: 23595577
[TBL] [Abstract][Full Text] [Related]
32. A critical role for CK2 in cytokine-induced activation of NFκB in pancreatic β cell death.
Jaksch C; Thams P
Endocrine; 2014 Sep; 47(1):117-28. PubMed ID: 24366643
[TBL] [Abstract][Full Text] [Related]
33. Deoxynucleosides with benzimidazoles as aglycone moiety are potent anticancer agents.
Koronkiewicz M; Chilmonczyk Z; Kazimerczuk Z; Orzeszko A
Eur J Pharmacol; 2018 Feb; 820():146-155. PubMed ID: 29246854
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of new analogs of benzotriazole, benzimidazole and phthalimide--potential inhibitors of human protein kinase CK2.
Najda-Bernatowicz A; Łebska M; Orzeszko A; Kopańska K; Krzywińska E; Muszyńska G; Bretner M
Bioorg Med Chem; 2009 Feb; 17(4):1573-8. PubMed ID: 19168362
[TBL] [Abstract][Full Text] [Related]
35. Tenfibgen-DMAT Nanocapsule Delivers CK2 Inhibitor DMAT to Prostate Cancer Xenograft Tumors Causing Inhibition of Cell Proliferation.
Trembley JH; Unger GM; Gomez OC; Abedin J; Korman VL; Vogel RI; Niehans G; Kren BT; Ahmed K
Mol Cell Pharmacol; 2014; 6(2):15-25. PubMed ID: 25893034
[TBL] [Abstract][Full Text] [Related]
36. Halogenated imidazole derivatives block RNA polymerase II elongation along mitogen inducible genes.
Mikula M; Hanusek K; Paziewska A; Dzwonek A; Rubel T; Bomsztyk K; Ostrowski J
BMC Mol Biol; 2010 Jan; 11():4. PubMed ID: 20078881
[TBL] [Abstract][Full Text] [Related]
37. Protein kinase CK2 promotes cancer cell viability via up-regulation of cyclooxygenase-2 expression and enhanced prostaglandin E2 production.
Yefi R; Ponce DP; Niechi I; Silva E; Cabello P; Rodriguez DA; Marcelain K; Armisen R; Quest AF; Tapia JC
J Cell Biochem; 2011 Nov; 112(11):3167-75. PubMed ID: 21732411
[TBL] [Abstract][Full Text] [Related]
38. Antitumor activity of the protein kinase inhibitor 1-(β-D-2'-deoxyribofuranosyl)-4,5,6,7-tetrabromo- 1H-benzimidazole in breast cancer cell lines.
Koronkiewicz M; Kazimierczuk Z; Orzeszko A
BMC Cancer; 2022 Oct; 22(1):1069. PubMed ID: 36243702
[TBL] [Abstract][Full Text] [Related]
39. Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole.
Pagano MA; Andrzejewska M; Ruzzene M; Sarno S; Cesaro L; Bain J; Elliott M; Meggio F; Kazimierczuk Z; Pinna LA
J Med Chem; 2004 Dec; 47(25):6239-47. PubMed ID: 15566294
[TBL] [Abstract][Full Text] [Related]
40. N-Aryl-N'-(chroman-4-yl)ureas and thioureas display in vitro anticancer activity and selectivity on apoptosis-resistant glioblastoma cells: screening, synthesis of simplified derivatives, and structure-activity relationship analysis.
Goffin E; Lamoral-Theys D; Tajeddine N; de Tullio P; Mondin L; Lefranc F; Gailly P; Rogister B; Kiss R; Pirotte B
Eur J Med Chem; 2012 Aug; 54():834-44. PubMed ID: 22809560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
